Your browser doesn't support javascript.
loading
Ångstrom-scale silver particles potently combat SARS-CoV-2 infection by suppressing the ACE2 expression and inflammatory responses.
Deng, Yong-Qiang; Wang, Zhen-Xing; Liu, Xin; Wang, Yi-Yi; Chen, Qi; Li, Zhao-Long; Zheng, Bai-Song; Ye, Qing; Gong, Jiang-Shan; Zhu, Guo-Qiang; Cao, Tian-Shu; Situ, Wei-Yi; Qin, Cheng-Feng; Xie, Hui; Zhang, Wen-Yan.
Afiliação
  • Deng YQ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China. qincf@bmi.ac.cn.
  • Wang ZX; Department of Orthopedics, Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. huixie@csu.edu.cn.
  • Liu X; Angmedicine Research Center of Central South University, Changsha, Hunan 410008, China.
  • Wang YY; Xiangya Hospital of Central South University-Amcan Pharmaceutical Biotechnology Co. Ltd. Collaborating Research Center, Changsha, Hunan 410008, China.
  • Chen Q; Institute of Virology and AIDS Research, Key laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China. zhangwenyan@jlu.edu.cn.
  • Li ZL; Department of Orthopedics, Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. huixie@csu.edu.cn.
  • Zheng BS; Angmedicine Research Center of Central South University, Changsha, Hunan 410008, China.
  • Ye Q; Xiangya Hospital of Central South University-Amcan Pharmaceutical Biotechnology Co. Ltd. Collaborating Research Center, Changsha, Hunan 410008, China.
  • Gong JS; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China. qincf@bmi.ac.cn.
  • Zhu GQ; Institute of Virology and AIDS Research, Key laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China. zhangwenyan@jlu.edu.cn.
  • Cao TS; Institute of Virology and AIDS Research, Key laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China. zhangwenyan@jlu.edu.cn.
  • Situ WY; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China. qincf@bmi.ac.cn.
  • Qin CF; Department of Orthopedics, Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. huixie@csu.edu.cn.
  • Xie H; Angmedicine Research Center of Central South University, Changsha, Hunan 410008, China.
  • Zhang WY; Xiangya Hospital of Central South University-Amcan Pharmaceutical Biotechnology Co. Ltd. Collaborating Research Center, Changsha, Hunan 410008, China.
J Mater Chem B ; 10(28): 5454-5464, 2022 07 20.
Article em En | MEDLINE | ID: mdl-35786741
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article